A quoted vial price does not tell you what an England buyer will pay for treatment-ready eribulin. By separating dose cost, wastage, Incoterms, import charges, regulatory evidence and delivery risk, you can request a comparable quotation and identify when an overseas supply route is unsuitable.
Key takeaways
- Confirm 0.44 mg/mL, 2 mL and 0.88 mg per vial.
- Separate eribulin content from eribulin mesilate equivalent in every quote.
- Calculate doses, vial waste, freight, duties and temperature-control costs.
- Request batch documents, shelf-life data and England import paperwork before ordering.
What an exporter’s eribulin vial price must include
An “eribulin 0 point 44 mg ml vial price” is comparable only when the product is identified as eribulin 0.44 mg/mL in a 2 mL single-use vial. It contains 0.88 mg of eribulin, equivalent to 1 mg of eribulin mesilate; require the quote to state which expression it uses.
Ask an eribulin mesylate injection supplier to confirm finished, labelled and released medicine, not API or bulk solution.
| Term | What the quoted price includes | Buyer’s exposure |
|---|---|---|
| EXW | Goods made available at the seller’s premises | You arrange collection and export |
| FOB | Export clearance and loading aboard the vessel | You pay main freight and insurance |
| CIF | Freight and insurance to a named port | You handle import clearance, duties and delivery |
| DAP | Delivery to the named destination | You pay import duties and taxes |
| DDP | Delivery with seller-arranged import obligations | Confirm the importer and lawful route into England |
Request a written quotation containing:
- Currency, price per vial, 10-vial minimum order and volume tiers
- Quote validity period, payment method and payment timing
- Available batch number, release status, expiry and remaining shelf life
- Incoterm, named place or port, freight, insurance, taxes and duties
- Exact manufacturer, site, pack configuration and storage conditions
- Confirmation that DDP arrangements identify the lawful importer for medicines entering England
No price should be compared until these fields are complete.
How vial price becomes treatment cost
At a body-surface area of 1.7 m², the licensed eribulin dose calculates to about 2.09 mg per administration. The licensed schedule is intravenous treatment on days 1 and 8 of a 21-day cycle; confirm every treatment decision against the current product information and an oncology pharmacist.
A 0.88 mg vial therefore does not equal one dose. Three 0.88 mg vials provide 2.64 mg, leaving unused solution. The vial is single-use and preservative-free, so ask an eribulin injection exporter how opened-vial waste is handled; do not assume multidose pooling is permitted.
Compare treatment cost, not just the unit price:
- Vial price × vials required per administration × administrations per cycle = medicine cost per cycle.
- Record wastage separately.
- Record any dose rounding separately under the local protocol.
- Repeat the calculation using the actual pack size, not a rounded “one dose” assumption.
The licensed uses are advanced breast cancer after specified prior therapy and unresectable or metastatic liposarcoma after prior anthracycline therapy. This procurement calculation is not a dosing protocol.
Dose reductions or interruptions linked to hepatic impairment, renal impairment, neutropenia and peripheral neuropathy can change vial consumption and scheduling. Assess stock flexibility, minimum order quantities and lead time against dose-modified treatment, because the lowest per-vial offer can produce the highest cycle cost when it creates more waste or unusable excess stock.
What makes an England-bound quotation legally usable
An England-bound quotation is usable only when it identifies a lawful Great Britain supply route for the finished medicine, not merely an export-capable factory. An Indian manufacturing licence, WHO-GMP certificate or export registration alone does not authorise routine commercial placement in England.
| Supply route | What it must establish | What it does not establish |
|---|---|---|
| Routine commercial supply | UK marketing authorisation, compliant importer and licensed wholesale arrangements | That an Indian export approval permits sale |
| Named-patient or specials supply | A specific lawful unlicensed-medicine route for an identified patient or clinical need | Permission for routine promotional sale |
Ask the eribulin mesylate injection supplier for:
- Exact legal manufacturer, manufacturing site and batch-release location
- UK marketing-authorisation status, or the precise lawful supply route
- Importer identity and responsibility for wholesale licensing
- Commercial invoice, packing list, certificate of analysis and batch-release documents
- Certificate of origin, product information, import paperwork and traceability records
“Available for export” does not prove suitability for eribulin oncology supply in England. The hospital, clinic, wholesaler or pharmacy must verify the product, labelling, importer and recipient account before paying a deposit.
NHS Drug Tariff figures, NHS framework or local procurement prices, and NICE recommendations do not set the price an Indian exporter can offer. They describe reimbursement, procurement or clinical-economic context, not a lawful exporter quotation under its stated Incoterm.
Specials or named-patient arrangements cannot be used as substitutes for ordinary commercial supply of an unlicensed product.
How to compare landed cost, shelf life and transport risk
Calculate delivered cost as: product total plus export handling, freight, insurance, customs duty, import VAT, customs-clearance charges, broker fees and final delivery. Record the following on every competing quote, because different assumptions can make identical vial prices look different.
| Cost or term | What to record |
|---|---|
| Product | Vial quantity, currency and product total |
| Trade terms | Named Incoterm and destination |
| Import charges | Tariff treatment, duty rate and tax assumptions |
| Currency | Conversion basis, date and exchange-rate source |
| Delivery | Dispatch date and delivery window |
Require the exporter to state minimum remaining shelf life at dispatch and at delivery, batch release date, expiry date and its short-dated-stock policy. A cheaper batch with six months less usable life can create replacement or disposal costs.
Ask how storage below 30°C is maintained during transit. Require validated packaging, temperature monitoring, freezing protection, excursion records and a documented response if customs delays the consignment.
On arrival, check:
- Intact tamper evidence
- Readable batch and expiry details
- Vial and stopper condition
- Shipment temperature records
- Certificate and shipment details matching
- A named recall-reporting contact
Compare like with like across manufacturers, pack configurations and lawful presentations. Do not compare a finished 2 mL vial with eribulin API, bulk solution or a different strength. A quote is not comparable until its landed-cost assumptions and product identity match.
A practical request-and-order workflow for an England buyer
An England buyer should begin by naming the authorised recipient, such as a licensed wholesaler, hospital pharmacy or clinic, and confirming the lawful supply route before discussing payment. Send “eribulin mesylate 0.44 mg/mL, 2 mL vial” with forecast quantity, delivery destination and required date.
- Ask for available stock, batch number, expiry date, remaining shelf life, certificate of analysis, batch-release evidence, product information, labels, Incoterm and landed-cost assumptions.
- Verify the legal manufacturer, manufacturing site, batch-release location, importer and relevant UK licences or marketing-authorisation route. An Indian licence or WHO-GMP certificate alone does not authorise routine Great Britain supply.
- Reserve the identified batch only after checking shipping validation, storage below 30°C, temperature monitoring, freezing protection and customs-delay arrangements.
- Have the oncology pharmacist review the current product information: administration is intravenous over approximately 2–5 minutes, and intrathecal administration is prohibited. A sales sheet cannot replace this check.
- Approve documents and labels, agree payment timing and method, then schedule dispatch with a customs contingency and named recall contact.
NIBA HEALTHCARE can be approached as an eribulin injection exporter for a product-level quotation, but request current commercial and regulatory evidence rather than relying on a general exporter page.
| Checkpoint | Evidence | Decision |
|---|---|---|
| Supply route | Authorised recipient and lawful route | Proceed only when documented |
| Batch | Stock, expiry and release records | Reserve only after review |
| Delivery | Validated shipping and customs plan | Dispatch only with contingency |
Stop and choose another source if you need a different strength, faster delivery, longer shelf life, locally authorised presentation or UK-specific regulatory support that the exporter cannot document. This discipline protects an eribulin oncology supply in England from becoming an unusable purchase.
Related product
Frequently asked questions
What must an eribulin exporter include in the vial price?
The quote must identify eribulin 0.44 mg/mL in a 2 mL single-use vial, state whether the price uses 0.88 mg of eribulin or 1 mg of eribulin mesilate equivalent, and list packaging, freight, insurance, duties and other charges separately.
How does an eribulin vial price become the treatment cost?
Calculate the prescribed dose, the number of vials required, any unavoidable vial waste and the treatment schedule. Then add freight, import charges, handling and temperature-controlled transport costs to the product price.
What documents make an eribulin quotation usable for England?
Ask for the product specification, batch number, certificate of analysis, expiry date, storage conditions, pack details, manufacturer information and the licences or import documentation required for the intended England supply route.
How should an England buyer compare eribulin suppliers?
Compare the complete landed cost alongside remaining shelf life, validated transport conditions, shipment insurance, replacement terms for temperature excursions, batch documentation and delivery timing—not the vial price alone.
Related product
 | Anti Cancer Injection Minimum order quanity 10 Vial Strength 0.44 mg/ml Packaging Type Vial Packaging Size 2 ml Vial STORAGE CONDITION Store below 30 Degree C Country of... View product → |
